reSee.it - Tweets Saved By @jeffgilchrist

Saved - December 3, 2023 at 5:39 PM

@jeffgilchrist - Jeff Gilchrist

COVID-19: Pediatric Diabetes, Lung Damage, Brain Impact, Newborns, and Higher Hospitalization Rates Studies show kids are also at risk of long-term consequences from infection and especially those <5 for higher rates of hospitalization than most adults. Let's take a look.🧡1/ https://t.co/ByAxr8XphO

Saved - September 12, 2023 at 1:16 AM
reSee.it AI Summary
@jeffgilchrist shared a thread discussing Novavax and Moderna XBB.1.5 Fall Booster Performance. The conversation included links to a one-page web view and specific sections on pseudoviruses, Novavax results, Moderna results, and immune imprinting.

@jeffgilchrist - Jeff Gilchrist

Novavax & Moderna XBB.1.5 Fall Booster Performance The table of contents and link for the unrolled one-page version of the thread can be found in the next tweet once it is posted. πŸ‘‡

@jeffgilchrist - Jeff Gilchrist

The one page web view is available here: https://threadreaderapp.com/thread/1701396947871916279.html Start: Pseudoviruses: Novavax Results: Moderna Results: Immune Imprinting:

Thread by @jeffgilchrist on Thread Reader App @jeffgilchrist: Novavax & Moderna XBB.1.5 Fall Booster Performance This thread provides some data from preprint studies about how well the updated #Novavax and #Moderna #booster #vaccine performs on recent #variants...… threadreaderapp.com

@jeffgilchrist - Jeff Gilchrist

Novavax & Moderna XBB.1.5 Fall Booster Performance This thread provides some data from preprint studies about how well the updated #Novavax and #Moderna #booster #vaccine performs on recent #variants including some details on #immune #imprinting. 🧡1/

@jeffgilchrist - Jeff Gilchrist

** Pseudoviruses ** The other thing to point out is that the tests are using pseudovirus which is an approximation of the real thing so they can be conducted in lower biosafety level labs. 7/

@jeffgilchrist - Jeff Gilchrist

** Novavax Results ** Novavax included results with non-human primates were they tested a scenario with 2 original doses of vaccine and then a single XBB.1.5 booster which may be more likely for people who never got any kind of bivalent vaccine or Omicron COVID-19 infection. 15/

@jeffgilchrist - Jeff Gilchrist

** Moderna Results ** Moderna also released a preprint of their updated XBB.1.5 booster performance with pseudovirus lab test results involving humans test subjects ( https://www.medrxiv.org/content/10.1101/2023.08.22.23293434v2.full-text ). 19/

Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines medRxiv - The Preprint Server for Health Sciences medrxiv.org

@jeffgilchrist - Jeff Gilchrist

** Immune Imprinting ** A number of people have been asking if the latest variants have changed so much, do we just need one booster dose of the updated vaccine or do we need two doses to be effective? 26/

Saved - September 10, 2023 at 5:02 PM
reSee.it AI Summary
Novavax is a protein-based vaccine that presents the full COVID-19 Spike protein in nanoparticles. In contrast, mRNA vaccines get immune cells to produce copies of the Spike protein. Novavax uses an adjuvant called MatrixM, which enhances the immune response. Studies show Novavax has fewer side effects and better recognition of variant locations. Mixing Novavax with mRNA vaccines can enhance immunity and reduce breakthrough infections. Good indoor air quality is crucial for health, and personal filters like N95 masks can provide protection. Filters and masks work by using the laws of physics to stop tiny particles.

@jeffgilchrist - Jeff Gilchrist

#Novavax vs mRNA vaccine This thread explains how @Novavax is different from the #Moderna and #Pfizer #mRNA #vaccines and describes some of the benefits such as broadened #variant recognition, more durable #immunity, and fewer side effects. 🧡1/

@jeffgilchrist - Jeff Gilchrist

An unrolled one-page web view for this long thread that may be easier to read or share can be found here ( ). 2/

@jeffgilchrist - Jeff Gilchrist

Novavax is a protein based vaccine (similar designs have also been used for many years for tetanus, diphtheria and hepatitis B). Novavax presents the full COVID-19 Spike protein in nanoparticles designed to mimic the structure of the virus itself ( https://novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology ). 3/

Recombinant Nanoparticle Vaccine Technology | Novavax Learn about recombinant nanoparticle vaccine technology from Novavax. Recombinant vaccine engineering takes a new approach to providing immunity. novavax.com

@jeffgilchrist - Jeff Gilchrist

mRNA vaccines on the other hand get your immune cells to produce copies of the full Spike protein as single Spikes on their own which may interact differently with the immune system than Novavax's multi-Spike arrangement around a core. 4/

@jeffgilchrist - Jeff Gilchrist

This video shows you how the mRNA Spikes are produced in your body ( https://www.youtube.com/watch?v=8nD6Q9X0SFw ). 5/

@jeffgilchrist - Jeff Gilchrist

Another big difference between Novavax and the mRNA vaccines is that Novavax uses an adjuvant called Matrix-M made from the soapbark tree to enhance the immune response to the vaccine. 6/

@jeffgilchrist - Jeff Gilchrist

This adjuvant induces early activation of innate immune cells at the injection site and in the draining lymph nodes ( https://www.tandfonline.com/doi/full/10.1080/21645515.2023.2189885 ). H/T: @paulseaman31 7/

@jeffgilchrist - Jeff Gilchrist

You can read the study to to get much more details about the mechanisms of action with Matrix-M, including interesting facts such as within 24 hours both the Spike antigens and adjuvant are undetectable at the injection site... 8/

@jeffgilchrist - Jeff Gilchrist

...since they have already been processed and transported to the draining lymph nodes by immune cells. I wonder if that is one of the reasons why many people feel much less pain in their arms after injection compared to mRNA shots? 9/

@jeffgilchrist - Jeff Gilchrist

Using Matrix-M translates into an improved magnitude and quality of the antibody response to the Spike protein (antigen) and importantly broadened recognition of locations on the Spike (epitopes). 10/

@jeffgilchrist - Jeff Gilchrist

This improvement was actually seen in the real world with the BA.1 and BA.5 variants and the original Novavax vaccine formula. 11/

@jeffgilchrist - Jeff Gilchrist

Both Pfizer and Moderna released bivalent BA.1/BA.5 vaccines in fall 2022 since the antibodies generated from their original mRNA vaccines could no longer neutralize these newer Omicron variants. 12/

@jeffgilchrist - Jeff Gilchrist

Novavax however did not release a bivalent vaccine because their original vaccine formula with Matrix-M still worked with the BA.1 and BA.5 variants. 13/

@jeffgilchrist - Jeff Gilchrist

The Matrix-M adjuvant elicited antibodies from a broader set of locations on the Spike protein (epitopes) so even when some of the locations mutated with BA.1 and BA.5, the conserved locations could still be recognized by the immune system. ( https://www.medrxiv.org/content/10.1101/2023.05.31.23290594v1.full ). 14/

Protein Vaccine Demonstrates Less Reactogenicity than mRNA – A Real World Study medRxiv - The Preprint Server for Health Sciences medrxiv.org

@jeffgilchrist - Jeff Gilchrist

There have also been suggestions to improve mRNA vaccine potency, durability, safety and T-cell response by using adjuvants ( https://www.nature.com/articles/s41551-023-01082-6 ). 15/

Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA - Nature Biomedical Engineering To elicit optimal immune responses, messenger RNA vaccines require intracellular delivery of the mRNA and the careful use of adjuvants. Here we report a multiply adjuvanted mRNA vaccine consisting of lipid nanoparticles encapsulating an mRNA-encoded antigen, optimized for efficient mRNA delivery and for the enhanced activation of innate and adaptive responses. We optimized the vaccine by screening a library of 480 biodegradable ionizable lipids with headgroups adjuvanted with cyclic amines and by adjuvanting the mRNA-encoded antigen by fusing it with a natural adjuvant derived from the C3 complement protein. In mice, intramuscular or intranasal administration of nanoparticles with the lead ionizable lipid and with mRNA encoding for the fusion protein (either the spike protein or the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) increased the titres of antibodies against SARS-CoV-2 tenfold with respect to the vaccine encoding for the unadjuvanted antigen. Multiply adjuvanted mRNA vaccines may improve the efficacy, safety and ease of administration of mRNA-based immunization. Adjuvanting the lipid and the encapsulated messenger RNA-encoded antigen in lipid-nanoparticle mRNA vaccines can enhance the efficiency of mRNA delivery and the activation of the immune responses, as shown for a COVID-19 vaccine in mice. nature.com

@jeffgilchrist - Jeff Gilchrist

In mice they found the adjuvant in mRNA vaccines increased antibody levels 10x and produced Fc-binding antibodies which showed better control over viral replication and help predict resolution of severed COVID-19 ( ). 16/

@jeffgilchrist - Jeff Gilchrist

Many people have anecdotally discovered and reported that Novavax doses had much lower side effects than when they received an mRNA shot. 17/

@jeffgilchrist - Jeff Gilchrist

Multiple studies have now shown this to be the case as well. One preprint study (supported by Novavax) that compares the reactogenicity (frequency of side effects) of Novavax and mRNA vaccines ( https://medrxiv.org/content/10.1101/2023.05.31.23290594v1.full ). H/T: @michaelzlin 18/

Protein Vaccine Demonstrates Less Reactogenicity than mRNA – A Real World Study medRxiv - The Preprint Server for Health Sciences medrxiv.org

@jeffgilchrist - Jeff Gilchrist

They found a notable difference in the percentage of reported side effect symptoms with Novavax being lower in each category: * 30.8% lower muscle pain * 30.4% lower injection site pain * 25.7% lower fatigue * 25.4% lower injection site tenderness * 24.9% lower malaise 19/

@jeffgilchrist - Jeff Gilchrist

* 22.4% lower swelling * 18.3% lower headache * 17.5% lower joint pain * 13% lower redness * 12% lower fever * 3.5% lower nausea/vomiting 20/

@jeffgilchrist - Jeff Gilchrist

What about people who had mRNA doses previously but want to consider Novavax? There have been several studies now that found mixing the two, getting mRNA and then Novavax actually gave better results than just mRNA on its own. 21/

@jeffgilchrist - Jeff Gilchrist

One study found that getting Novavax as a booster after mRNA "may enhance the persistence and durability of vaccine-mediated immunity compared to mRNA options"... 22/

@jeffgilchrist - Jeff Gilchrist

...with slower decay rate compared to an mRNA booster dose and less side effects than mRNA boosters ( https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2232020 ). H/T: @Daniel_E_Park 23/

@jeffgilchrist - Jeff Gilchrist

A randomized controlled trial found that getting a Novavax dose after Pfizer mRNA elicited the highest humoral and peak cellular immune responses ( https://www.journalofinfection.com/article/S0163-4453(23)00330-4/fulltext ). H/T: @michaelzlin 24/

@jeffgilchrist - Jeff Gilchrist

The mRNA + Novavax combination also had the lowest rate of breakthrough infections and the study also found fewer moderate and severe systemic adverse effects for Novavax than Pfizer mRNA. 25/

@jeffgilchrist - Jeff Gilchrist

Neutralising antibodies against Omicron BA.1 and BA.2 were higher with Novavax after mRNA compared to two mRNA doses. 26/

@jeffgilchrist - Jeff Gilchrist

Now you have more details as to how Novavax is different and some of the nice benefits including for people who had mRNA shots previously. 27/

@jeffgilchrist - Jeff Gilchrist

I'm hoping that the Matrix-M adjuvant will again show its ability to broaden the immune system's ability to choose epitopes so that it might continue to work better for upcoming variants as it did when BA.1 and BA.5 emerged. 28/

@jeffgilchrist - Jeff Gilchrist

FYI, I do not work for Novavax or have any investments or make any money from Novavax selling products. 29/

@jeffgilchrist - Jeff Gilchrist

I am a little confused as to why @Novavax just recently filed their regulatory approval paperwork with Health Canada as many people are waiting for the fall boosters so it would be a shame if they were not available soon like the mRNA fall boosters are expected to be. 30/

@jeffgilchrist - Jeff Gilchrist

While vaccines are important, they should be the last layer of protection to rely on in case all the other layers fail and you get exposed. Vaccines should not be the one and only layer governments all seem to be currently relying on. 31/ Click "Show replies" πŸ‘‡ to continue.

@jeffgilchrist - Jeff Gilchrist

ASHRAE Standard 241, Control of Infectious Aerosols ( https://www.ashrae.org/technical-resources/bookstore/ashrae-standard-241-control-of-infectious-aerosols ) was released in July 2023 so this should now be adopted and required in air quality standards for buildings like governments already require clean drinking water standards for these same buildings.32/

ASHRAE Standard 241, Control of Infectious Aerosols | ashrae.org Learn more about ASHRAE Standard 241, Control of Infectious Aerosols at ashrae.org ashrae.org

@jeffgilchrist - Jeff Gilchrist

It is important to have good indoor air quality, not just from viruses but also for cognitive function and from other air pollutants (like wildfire smoke) which have been linked to various health problems ( https://t.co/t9DLMBZiu9 ). 33/

@jeffgilchrist - Jeff Gilchrist

Aerosol and particulate matter (PM) particles can also be filtered and removed from the air using HVAC filters like MERV-13 or better, HEPA filters, build yourself CR-boxes with traditional fans or super quiet versions with PC fans. 34/

@jeffgilchrist - Jeff Gilchrist

You can find guides and useful information on my website ( http://covid.gilchrist.ca ). 35/

@jeffgilchrist - Jeff Gilchrist

Since you don't have control over the air quality in most public spaces you can also use personal filters (aka masks) with a good seal designed to protect from airborne pathogens like N95 respirators. 36/

@jeffgilchrist - Jeff Gilchrist

To find out how well your mask seals, you can see my thread on fit testing ( https://t.co/aTQfbtru41 ) and some of the test results I got comparing masks ( https://t.co/dSvpuaoeKM ). 37/

@jeffgilchrist - Jeff Gilchrist

Some people misunderstand and think filters such as HEPA and mask material work like a sieve or chain link fence which allow smaller objects like flies to pass through. 38/

@jeffgilchrist - Jeff Gilchrist

This thread explains how the laws of physics are used to allow the filtering material to stop such tiny smoke and aerosol particles ( https://t.co/tvw0UorQzy ). 39/

Saved - August 31, 2023 at 3:39 PM
reSee.it AI Summary
Novavax, a protein subunit vaccine, has gained attention for its efficacy against COVID-19. It utilizes purified parts of the Spike protein and an adjuvant to enhance the immune response. Novavax's proteins are assembled into nanoparticles resembling the virus structure. The vaccine remains effective against Omicron variants and offers longer-lasting protection. Combining Novavax with mRNA vaccines shows promising results, with higher antibody levels. Novavax elicits fewer side effects and may stimulate mucosal immunity. Its use of conserved spike protein regions contributes to its effectiveness. Novavax provides an alternative option for COVID-19 vaccination.

@jeffgilchrist - Jeff Gilchrist

COVID-19: How good is a Novavax booster and with previous mRNA doses? This long thread explores what kind of immune response a Novavax booster is giving people as a primary series and after 2 or 3 mRNA doses in recent studies, and what some of the benefits seem to be. 🧡1/

@jeffgilchrist - Jeff Gilchrist

The majority of people in North America and many parts of the world have had mRNA COVID-19 vaccines from Moderna or Pfizer but another type of vaccine (Novavax) has been making waves since its approval. 2/

@jeffgilchrist - Jeff Gilchrist

Novavax is a protein subunit vaccine that presents purified parts of the Spike protein, where mRNA vaccines get your cells to produce copies of the entire Spike protein. Protein based vaccines have been used for many years including for tetanus, diphtheria and hepatitis B. 3/

@jeffgilchrist - Jeff Gilchrist

The Novavax proteins are actually created in a type of moth cell. Since protein subunits on their own don't elicit a strong immune response, the vaccine also uses an adjuvant (made from soapbark tree) to increase the response which is a common technique used in vaccines. 4/

@jeffgilchrist - Jeff Gilchrist

The proteins are assembled into nanoparticles designed to mimic the structure of the COVID-19 virus as shown in the diagram. More details on how the Novavax vaccine is produced can be found here ( https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology ). 5/

Recombinant Nanoparticle Vaccine Technology | Novavax Learn about recombinant nanoparticle vaccine technology from Novavax. Recombinant vaccine engineering takes a new approach to providing immunity. novavax.com

@jeffgilchrist - Jeff Gilchrist

Sections of Spike protein that Novavax chose have been well conserved (97%) across multiple variants (Wuhan, BA.1, BA.2, BA.4) so the original formula is actually holding up very well against the latest Omicron variants ( https://youtu.be/BFdzNUus_CE?t=11619 ). H/T: @SocialFuzzer 6/

@jeffgilchrist - Jeff Gilchrist

In addition to Novavax holding up better against newer variants, its protection also seems to last longer before waning. 7/

@jeffgilchrist - Jeff Gilchrist

Novavax presented to the FDA in June 2022 showing that efficacy against variants of interest and variants of concern remained high despite the virus undergoing significant mutation ( https://youtu.be/BFdzNUus_CE?t=11603 ). 8/

@jeffgilchrist - Jeff Gilchrist

Strong protection against any infection (symptomatic and asymptomatic illness) remained above 71% (USA/Mexico) and 83% (UK) after 6 months. Every dose of vaccine allows the immune system to identify and learn about more sections of the protein. 9/

@jeffgilchrist - Jeff Gilchrist

With Novavax using better conserved proteins, after 3 doses it has a huge increase in neutralization ability even against variants such as BA.1 (purple) and BA.4/5 (blue) ( https://www.medrxiv.org/content/10.1101/2022.11.18.22282414v1.full-text ). 10/

Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial medRxiv - The Preprint Server for Health Sciences medrxiv.org

@jeffgilchrist - Jeff Gilchrist

After the 4th dose of Novavax, they reach levels seen in the clinical trial against the original Wuhan variant (which Novavax calls their prototype vaccine) that provided 95% efficacy. 11/

@jeffgilchrist - Jeff Gilchrist

What is really interesting is that you can see in the antigenic cartography diagram that additional doses reduce antigenic distance for broader recognition of new variants ( https://www.medrxiv.org/content/10.1101/2022.11.18.22282414v1.full-text ). 12/

Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial medRxiv - The Preprint Server for Health Sciences medrxiv.org

@jeffgilchrist - Jeff Gilchrist

With 2 doses of Novavax, there is a 33.5x difference between the original Wuhan variant and BA.4/5, which decreases to 7.1x after 3 doses, and only 3.5x after 4 doses which they attributed to the conserved parts of the spike protein between the variants. 13/

@jeffgilchrist - Jeff Gilchrist

Is Novavax working on a BA.1 specific or Bivalent vaccine like Pfizer/Moderna? They have actually tested both versions of a vaccine but since the spike proteins they used are so conserved between variants, the original vaccine formula performed just as well... 14/

@jeffgilchrist - Jeff Gilchrist

...as both the BA.1 specific and bivalent vaccines against BA.5 so did not warrant them asking the FDA to approve an updated bivalent formula in the summer ( https://filecache.investorroom.com/mr5ir_novavax2/187/download/3Q22-FINAL.pdf ). 15/

@jeffgilchrist - Jeff Gilchrist

People who started with Novavax and got 4 doses seem to be in a very good place but what about all the people who started getting mRNA (Moderna/Pfizer) or adenovirus (J&J/AZ) doses? How does adding Novavax doses compare for this group? 16/

@jeffgilchrist - Jeff Gilchrist

Novavax has been doing clinical trials with those groups as well. With 2 doses of Moderna or Pfizer, 1 dose of J&J and then receiving 1 Novavax booster were able to obtain Spike IgG antibody levels similar to the 2 dose Novavax phase 3 trials ( https://filecache.investorroom.com/mr5ir_novavax2/187/download/3Q22-FINAL.pdf ). 17/

@jeffgilchrist - Jeff Gilchrist

The graph shows for people with 3 doses of Moderna or Pfizer, 2 doses of J&J and then receiving 1 Novavax booster were above to get higher levels of IgG antibodies than the Novavax phase 3 trial ( https://filecache.investorroom.com/mr5ir_novavax2/187/download/3Q22-FINAL.pdf ). 18/

@jeffgilchrist - Jeff Gilchrist

How do 3 mRNA vaccine doses and a Novavax booster compare with the newer Omicron BA.1 and BA.5 variants? As you can see from the graph antibody levels with BA.1 and BA.5 are higher than the levels which achieved 88% vaccine efficacy ( https://filecache.investorroom.com/mr5ir_novavax2/187/download/3Q22-FINAL.pdf ). 19/

@jeffgilchrist - Jeff Gilchrist

Another study also looked at the response to the Omicron BA.1 and BA.5 variants for people who had 2 mRNA or 3 mRNA doses and then a Novavax booster dose ( https://www.journalofinfection.com/article/S0163-4453(22)00548-5/fulltext ). 20/

@jeffgilchrist - Jeff Gilchrist

They found that neutralization levels against BA.5 increased after the Novavax dose by: 3.8x = 2 mRNA + Novavax 2.5x = 3 mRNA + Novavax (not previously infected) 1.4x = 3 mRNA + Novavax (previously infected) 21/

@jeffgilchrist - Jeff Gilchrist

As found in previous studies, neutralization levels for those previously infected + vaccinated were much higher than those who had never been infected before. 22/

@jeffgilchrist - Jeff Gilchrist

Someone with 3 mRNA doses who were previously infected and received a Novavax booster dose did not significantly increase their antibody levels but hit some kind of ceiling. 23/

@jeffgilchrist - Jeff Gilchrist

While antibody levels may not be higher, it still may be possible that the immune system is learning more about the conserved regions of the spike so it may produce better quality antibodies. 24/

@jeffgilchrist - Jeff Gilchrist

The mRNA vaccines seem to provide a stronger reaction than most vaccines in the form of a very sore arm and other side effects so how does Novavax compare? 25/

@jeffgilchrist - Jeff Gilchrist

I have seen many reports from people saying they barely felt anything, no sore arm or for a very short period of time, nothing compared to their mRNA vaccine experience. 26/

@jeffgilchrist - Jeff Gilchrist

Surveillance reports also seem to be indicating the same thing, the AEFI report from Ontario to Nov. 20, 2022 shows that after 12,422 doses of Novavax given only a very small number of serious adverse events reported ( https://www.publichealthontario.ca/-/media/documents/ncov/epi/covid-19-aefi-report.pdf?la=en ). 27/

@jeffgilchrist - Jeff Gilchrist

The mRNA vaccines do not elicit very good mucosal immunity which are IgA antibodies located in the mucosa (nose, upper airways, etc..) where the virus enters your body. 28/

@jeffgilchrist - Jeff Gilchrist

Nasal vaccines are being developed to target this type of immunity but it seems that Novavax might actually elicit IgA antibodies as well. 29/

@jeffgilchrist - Jeff Gilchrist

Novavax found easily detectable levels of IgA antibodies in the mucosa of non-human primates after being vaccinated which may help explain why the efficacy is so high and could be providing sterilizing immunity ( https://youtu.be/BFdzNUus_CE?t=12507 ). 30/

@jeffgilchrist - Jeff Gilchrist

Novavax provides an alternative to other existing COVID-19 vaccines and since it uses more conserved regions of the spike protein, it continues to work well with newer variants, the protection wanes more slowly than other vaccines... Click "Show replies" πŸ‘‡to continue. 31/

@jeffgilchrist - Jeff Gilchrist

...people react less and have less side effects. The key is that you need multiple doses over time for your immune system to learn enough parts of the spike to identify it easily in newer variants. 32/

@jeffgilchrist - Jeff Gilchrist

In Canada, Novavax is approved as a primary series and booster dose for adults 18+ ( https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/novavax.html ). 33/

Novavax Nuvaxovid COVID-19 vaccine - Canada.ca Information on the Novavax COVID-19 vaccine including ingredients, how it works, how it's given, possible side effects and vaccine safety after authorization. canada.ca

@jeffgilchrist - Jeff Gilchrist

You can watch the entire Novavax presentation to the FDA on June 28, 2022, starting here: https://youtu.be/BFdzNUus_CE?t=11477 34/

@jeffgilchrist - Jeff Gilchrist

* Please note that I do not work for Novavax, do not have any investments or make any money from Novavax so no conflict of interest. 35/

@jeffgilchrist - Jeff Gilchrist

If you would like to share this thread with people outside of Twitter, you can use this link: https://pingthread.com/thread/1597228107919826946

Thread by jeffgilchrist: COVID-19: How good is a Novavax booster and with p... - PingThread COVID-19: How good is a Novavax booster and with previous mRNA doses? This long thread explores what kind of immune response a Novavax booster is giving people as a primary series and after 2 or 3 mRNA doses in recent studies, and what some of the benefits seem to be. 🧡1/ pingthread.com

@jeffgilchrist - Jeff Gilchrist

I wanted to clarify some wording that I used earlier in this thread that I can't edit now (thanks Twitter!) so it is accurate. Anywhere that refers to Novavax using more conserved parts of the spike protein should actually be... 36/

@jeffgilchrist - Jeff Gilchrist

...the antibodies elicited by the Novavax vaccine seem to bind to more conserved parts of the spike protein (epitopes) which may explain why it has higher neutralization against Omicron BA.5 even with the original formula. 37/

@jeffgilchrist - Jeff Gilchrist

The actual spike protein used by Novavax is the full spike except they modify the Furin Cleavage Site (FCS) so it can't be cut into separate S1 and S2 proteins. 38/

@jeffgilchrist - Jeff Gilchrist

The mRNA vaccines elicit antibodies for both S1 and S2 which is different than Novavax. With the mRNA vaccines your cells produce the full spike protein ( https://youtube.com/watch?v=8nD6Q9X0SFw ). 39/

@jeffgilchrist - Jeff Gilchrist

The Novavax vaccine presents the full spike but they are arranged around a core so may interact differently with the immune system than mRNA produced spikes ( https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology ). 40/

Recombinant Nanoparticle Vaccine Technology | Novavax Learn about recombinant nanoparticle vaccine technology from Novavax. Recombinant vaccine engineering takes a new approach to providing immunity. novavax.com

@jeffgilchrist - Jeff Gilchrist

From the FDA VRBPAC meeting in June 2022, Dr. Marasco comments that the form of the Novavax protein with an adjuvant is able to produce antibodies that have broader capability ( ). H/T: @paulseaman31 41/

@jeffgilchrist - Jeff Gilchrist

From the 4th dose study, "We believe this phenomenon may be driven by the conserved epitopes found on the recombinant protein vaccine whereby expression of the full-length trimers of the spike protein..." 42/

@jeffgilchrist - Jeff Gilchrist

"... present epitopes that are conserved across variants for recognition by the immune system." ( https://www.medrxiv.org/content/10.1101/2022.11.18.22282414v1.full ) 43/

Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial medRxiv - The Preprint Server for Health Sciences medrxiv.org

@jeffgilchrist - Jeff Gilchrist

** UPDATE ** this thread contains updated information on the Novavax vaccine from Jan. 26, 2023 including data on how well it compares to mRNA vaccines for BQ.1.1 and XBB.1 variants and data from the adolescent 12-17 clinical trial. See here ( https://t.co/2fdGqKNMX0 ). 44/

View Full Interactive Feed